Addus HomeCare Corporation Stock News

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Centene (CNC) and Moderna (MRNA) with bullish sentiments.

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Centene ( CNC – Research Report ) and Moderna ( MRNA – Research Report ) with bullish sentiments. C

Oppenheimer analyst Michael Wiederhorn maintained a Buy rating on Amedisys (AMED) today and set a price target of $215.00. The company's shares closed

Oppenheimer analyst Michael Wiederhorn maintained a Buy rating on Amedisys ( AMED – Research Report ) today and set a price target of $215.00 . The company’s shares closed last Friday at $186.50.

Bank of America Corp DE trimmed its holdings in shares of Addus Homecare Co. (NASDAQ:ADUS) by 13.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securiti

Addus Homecare (NASDAQ:ADUS)‘s stock had its “buy” rating reaffirmed by analysts at Royal Bank of Canada in a report released on Monday, AnalystRatings.com reports. They presently have a $98.00

After Credit Suisse and Barclays gave HCA Healthcare (NYSE: HCA) a Buy rating last month, the company received another Buy, this time from Oppenheimer.

After Credit Suisse and Barclays gave HCA Healthcare (NYSE: HCA) a Buy rating last month, the company received another Buy,

Addus Homecare Co. (NASDAQ:ADUS) has earned a consensus recommendation of “Hold” from the ten brokerages that are currently covering the firm, MarketBeat.com reports. One investment analyst has ra

In a report released today, Frank Morgan from RBC Capital maintained a Buy rating on Addus Homecare (ADUS), with a price target of $98.00. The company's

In a report released today, Frank Morgan from RBC Capital maintained a Buy rating on Addus Homecare ( ADUS – Research Report ), with a price target of $98.00 . The company’s shares closed last Fri

Wall Street brokerages predict that Addus Homecare Co. (NASDAQ:ADUS) will post $0.64 earnings per share for the current fiscal quarter, Zacks reports. Five analysts have provided estimates for Addus H

Wall Street analysts expect that Addus Homecare Co. (NASDAQ:ADUS) will post $181.08 million in sales for the current quarter, Zacks Investment Research reports. Five analysts have provided estimates f

Alliancebernstein L.P. lifted its holdings in shares of Addus Homecare Co. (NASDAQ:ADUS) by 7.4% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investo

6 Meridian acquired a new stake in Addus Homecare Co. (NASDAQ:ADUS) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acq